Robert W. Baird Forecasts Strong Price Appreciation for Smartstop Self Storage REIT (NYSE:SMA) Stock

Smartstop Self Storage REIT (NYSE:SMA) had its price target boosted by equities research analysts at Robert W. Baird from $36.00 to $37.00 in a research report issued to clients and investors on Monday,Benzinga reports. The firm currently has an “outperform” rating on the healthcare company’s stock. Robert W. Baird’s price objective would indicate a potential upside of 7.57% from the company’s current price.

SMA has been the topic of a number of other reports. Raymond James Financial assumed coverage on shares of Smartstop Self Storage REIT in a report on Wednesday, July 15th. They issued a “strong-buy” rating and a $39.00 price target on the stock. Wells Fargo & Company reaffirmed a “neutral” rating on shares of Smartstop Self Storage REIT in a research report on Friday, July 24th. Zacks Research upgraded shares of Smartstop Self Storage REIT from a “strong sell” rating to a “hold” rating in a research note on Friday, May 8th. Finally, Weiss Ratings raised shares of Smartstop Self Storage REIT from a “hold (c-)” rating to a “hold (c)” rating in a research report on Thursday, July 16th. Two research analysts have rated the stock with a Strong Buy rating, four have given a Buy rating, three have issued a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average target price of $36.56.

Smartstop Self Storage REIT Stock Performance

Shares of Smartstop Self Storage REIT stock opened at $34.40 on Monday. The business’s fifty day simple moving average is $33.06 and its 200 day simple moving average is $32.29. The firm has a market capitalization of $1.90 billion, a P/E ratio of 67.44 and a beta of 0.50. Smartstop Self Storage REIT has a 12 month low of $29.41 and a 12 month high of $39.77. The company has a current ratio of 5.28, a quick ratio of 5.33 and a debt-to-equity ratio of 0.89.

Smartstop Self Storage REIT (NYSE:SMA) last announced its quarterly earnings data on Wednesday, August 5th. The healthcare company reported $0.20 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.49 by ($0.29). The business had revenue of $79.28 million during the quarter. Smartstop Self Storage REIT had a net margin of 9.68% and a return on equity of 2.33%. Smartstop Self Storage REIT has set its FY 2026 guidance at 1.980-2.040 EPS. As a group, analysts anticipate that Smartstop Self Storage REIT will post 2 EPS for the current year.

Institutional Investors Weigh In On Smartstop Self Storage REIT

Several large investors have recently added to or reduced their stakes in the company. Principal Financial Group Inc. boosted its position in Smartstop Self Storage REIT by 10,361.9% during the fourth quarter. Principal Financial Group Inc. now owns 2,067,159 shares of the healthcare company’s stock worth $63,958,000 after purchasing an additional 2,047,400 shares during the period. Vanguard Group Inc. raised its position in shares of Smartstop Self Storage REIT by 122.2% in the fourth quarter. Vanguard Group Inc. now owns 3,576,922 shares of the healthcare company’s stock valued at $110,670,000 after purchasing an additional 1,967,321 shares during the period. Conversant Capital LLC bought a new stake in shares of Smartstop Self Storage REIT in the second quarter valued at approximately $36,098,000. Price T Rowe Associates Inc. MD lifted its stake in shares of Smartstop Self Storage REIT by 13.7% during the 4th quarter. Price T Rowe Associates Inc. MD now owns 5,913,679 shares of the healthcare company’s stock valued at $182,972,000 after buying an additional 710,871 shares in the last quarter. Finally, Rush Island Management LP bought a new position in Smartstop Self Storage REIT in the 4th quarter worth approximately $15,644,000.

About Smartstop Self Storage REIT

Symmetry Medical Inc (Symmetry) is a medical device solutions company, including surgical instruments, orthopedic implants, and sterilization cases and trays. The Company designs, develops and offers worldwide production and supply chain capabilities for these products to customers in the orthopedic industry, and other medical device markets (including but not limited to arthroscopy, dental, laparoscopy, osteobiologic, and endoscopy segments). It also manufactures specialized non-healthcare products, primarily in the aerospace industry.